drugset / Trial / NCT04947553
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the long-term safety and efficacy of AXS-05 in subjects with Alzheimer's disease (AD) agitation.
Timeline
- Start
- 2021-06-17
- Primary completion
- 2024-12-03
- Completion
- 2024-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | — | — |
| Subject | Dextromethorphan | Unknown | — | — |